SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Silverback Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 4, 2022 - SBTXPRNewsWire • 11/30/21
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Silverback Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmPRNewsWire • 11/26/21
Levi & Korsinsky, LLP, Researching Possible Securities Law Violations - Silverback Therapeutics, Inc. - SBTXPRNewsWire • 11/24/21
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Silverback Therapeutics, Inc. and Encourages Investors with Losses to Contact the FirmBusiness Wire • 11/23/21
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Silverback Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 11/22/21
SILVERBACK ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Silverback Therapeutics, Inc. and Encourages Investors to Contact the FirmBusiness Wire • 11/20/21
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Silverback Therapeutics, Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action - SBTXNewsfile Corp • 11/19/21
SILVERBACK THERAPEUTICS, INC. (SBTX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit regarding Silverback Therapeutics, Inc.Newsfile Corp • 11/19/21
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Silverback Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 11/19/21
SBTX Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Silverback Therapeutics, Inc. Investors of Class Action and Encourages Shareholders to Contact the FirmBusiness Wire • 11/16/21
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Silverback Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 11/15/21
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Silverback To Contact Him Directly To Discuss Their OptionsNewsfile Corp • 11/14/21
DEADLINE: Silverback Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - SBTXPRNewsWire • 11/13/21
ALERT: Silverback Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - SBTXNewsfile Corp • 11/13/21
SHAREHOLDER ALERT: Robbins LLP Reminds Investors that Silverback Therapeutics, Inc. (SBTX) is Being Sued for Misleading InvestorsBusiness Wire • 11/12/21
SBTX Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Silverback Therapeutics, Inc. Shareholders of Class Action and Encourages Investors to Contact the FirmPRNewsWire • 11/12/21
Silverback Therapeutics Presents SBT6050-201 Trial in Progress Poster at Society for Immunotherapy of Cancer's (SITC) 36th Annual MeetingBusiness Wire • 11/12/21
Silverback Therapeutics Presents Preclinical Data for SBT8230 at AASLD The Liver Meeting 2021Business Wire • 11/12/21
SBTX Investor News: Rosen, A Leading Law Firm, Encourages Silverback Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SBTXNewsfile Corp • 11/11/21
Silverback Therapeutics to Participate in the Stifel 2021 Virtual Healthcare ConferenceBusiness Wire • 11/11/21
INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Silverback Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 11/11/21
Silverback Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business UpdateBusiness Wire • 11/10/21
SBTX DEADLINE: Silverback Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitPRNewsWire • 11/10/21
ROSEN, A LEADING LAW FIRM, Encourages Silverback Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - SBTXPRNewsWire • 11/09/21
SILVERBACK THERAPEUTICS, INC. (NASDAQ: SBTX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Silverback Therapeutics, Inc.PRNewsWire • 11/09/21
